The European Medicines Agency (EMA) has warned against revaccinating against coronavirus more than three times a year or every four months - otherwise there is a risk of weakening the immune system of people. The world must begin the transition from a pandemic response to the coronavirus to an endemic one, similar to the long-established one for the influenza virus - with approved seasonal vaccination schedules.
"While the use of booster vaccines may remain part of contingency plans, a revaccination strategy at short intervals is not viable," told Reuters. Marco Cavaleri, head of EMA vaccination strategies,
The Agency still sees no evidence of benefit from the fourth dose of the vaccine (second booster) that Israel has already begun to use for vulnerable populations.
The EMA acknowledges that the collected data on the interaction of the omicron strain with vaccines and its epidemiological features are not yet sufficient to make a decision on the need for a specific omicron-specific vaccine. But if such a decision is made, new vaccines cannot be approved before April. With their massive use, worldwide coordination is needed, Cavaleri emphasized.